332 related articles for article (PubMed ID: 11546835)
21. Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats.
Micheli L; Di Cesare Mannelli L; Guerrini R; Trapella C; Zanardelli M; Ciccocioppo R; Rizzi A; Ghelardini C; Calò G
Eur J Pharmacol; 2015 May; 754():73-81. PubMed ID: 25704616
[TBL] [Abstract][Full Text] [Related]
22. Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120.
Fischetti C; Rizzi A; Gavioli EC; Marzola G; Trapella C; Guerrini R; Petersen JS; Calo G
Peptides; 2009 Feb; 30(2):248-55. PubMed ID: 18992780
[TBL] [Abstract][Full Text] [Related]
23. Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ.
Donica CL; Awwad HO; Thakker DR; Standifer KM
Mol Pharmacol; 2013 May; 83(5):907-18. PubMed ID: 23395957
[TBL] [Abstract][Full Text] [Related]
24. Structure activity studies of nociceptin/orphanin FQ(1-13)-NH2 derivatives modified in position 5.
Guerrini R; Marzola E; Trapella C; Pacifico S; Cerlesi MC; Malfacini D; Ferrari F; Bird MF; Lambert DG; Salvadori S; Calo G
Bioorg Med Chem; 2015 Apr; 23(7):1515-20. PubMed ID: 25716007
[TBL] [Abstract][Full Text] [Related]
25. Changes in expression of nociceptin/orphanin FQ and its receptor in spinal dorsal horn during electroacupuncture treatment for peripheral inflammatory pain in rats.
Fu X; Wang YQ; Wang J; Yu J; Wu GC
Peptides; 2007 Jun; 28(6):1220-8. PubMed ID: 17493706
[TBL] [Abstract][Full Text] [Related]
26. Functional coupling of the nociceptin/orphanin FQ receptor in dog brain membranes.
Johnson EE; McDonald J; Nicol B; Guerrini R; Lambert DG
Brain Res; 2004 Apr; 1003(1-2):18-25. PubMed ID: 15019559
[TBL] [Abstract][Full Text] [Related]
27. Site-specific estrogen and progestin regulation of orphanin FQ/nociceptin and nociceptin opioid receptor mRNA expression in the female rat limbic hypothalamic system.
Sinchak K; Romeo HE; Micevych PE
J Comp Neurol; 2006 May; 496(2):252-68. PubMed ID: 16538678
[TBL] [Abstract][Full Text] [Related]
28. UFP-112 a potent and long-lasting agonist selective for the Nociceptin/Orphanin FQ receptor.
Calo' G; Rizzi A; Cifani C; Micioni Di Bonaventura MV; Regoli D; Massi M; Salvadori S; Lambert DG; Guerrini R
CNS Neurosci Ther; 2011 Jun; 17(3):178-98. PubMed ID: 20497197
[TBL] [Abstract][Full Text] [Related]
29. The Nociceptin/Orphanin FQ System and the Regulation of Memory.
Moulédous L
Handb Exp Pharmacol; 2019; 254():259-278. PubMed ID: 30430261
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological characterization of nociceptin/orphanin FQ receptors, a novel opioid receptor family, in the midbrain periaqueductal gray.
Chiou LC; Fan SH; Chuang KC; Liao YY; Lee SZ
Ann N Y Acad Sci; 2004 Oct; 1025():398-403. PubMed ID: 15542742
[TBL] [Abstract][Full Text] [Related]
31. Modulation of synaptic transmission by nociceptin/orphanin FQ and nocistatin in the spinal cord dorsal horn of mutant mice lacking the nociceptin/orphanin FQ receptor.
Ahmadi S; Kotalla C; Gühring H; Takeshima H; Pahl A; Zeilhofer HU
Mol Pharmacol; 2001 Mar; 59(3):612-8. PubMed ID: 11179457
[TBL] [Abstract][Full Text] [Related]
32. Orphanin FQ/nociceptin blocks chronic morphine-induced tyrosine hydroxylase upregulation.
Thakker DR; Standifer KM
Brain Res Mol Brain Res; 2002 Sep; 105(1-2):38-46. PubMed ID: 12399106
[TBL] [Abstract][Full Text] [Related]
33. Assessment of the activity of a novel nociceptin/orphanin FQ analogue at recombinant human nociceptin/orphanin FQ receptors expressed in Chinese hamster ovary cells.
Wright KE; McDonald J; Barnes TA; Rowbotham DJ; Guerrini R; Calo' G; Lambert DG
Neurosci Lett; 2003 Aug; 346(3):145-8. PubMed ID: 12853105
[TBL] [Abstract][Full Text] [Related]
34. The effects of [Arg14, Lys15] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functions.
Broccardo M; Linari G; Guerrini R; Agostini S; Petrella C; Improta G
Peptides; 2005 Sep; 26(9):1590-7. PubMed ID: 16112397
[TBL] [Abstract][Full Text] [Related]
35. Molecular Mechanisms Mediating Nociceptin/Orphanin FQ Receptor Signaling, Desensitization and Internalization.
Baiula M; Bedini A; Carbonari G
Curr Mol Pharmacol; 2013 Jan; ():. PubMed ID: 23302003
[TBL] [Abstract][Full Text] [Related]
36. Binding and GTPgammaS autoradiographic analysis of preproorphanin precursor peptide products at the ORL1 and opioid receptors.
Neal CR; Owens CE; Taylor LP; Hoversten MT; Akil H; Watson SJ
J Chem Neuroanat; 2003 Jul; 25(4):233-47. PubMed ID: 12842269
[TBL] [Abstract][Full Text] [Related]
37. Regulation of pancreatic secretion in vitro by nociceptin/orphanin FQ and opioid receptors: a comparative study.
Linari G; Agostini S; Broccardo M; Petrella C; Improta G
Pharmacol Res; 2006 Nov; 54(5):356-60. PubMed ID: 16979347
[TBL] [Abstract][Full Text] [Related]
38. Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.
Toll L; Bruchas MR; Calo' G; Cox BM; Zaveri NT
Pharmacol Rev; 2016 Apr; 68(2):419-57. PubMed ID: 26956246
[TBL] [Abstract][Full Text] [Related]
39. Nociceptin/orphanin FQ-NOP receptor system in inflammatory and immune-mediated diseases.
Gavioli EC; de Medeiros IU; Monteiro MC; Calo G; Romão PR
Vitam Horm; 2015; 97():241-66. PubMed ID: 25677775
[TBL] [Abstract][Full Text] [Related]
40. [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.
Carrà G; Rizzi A; Guerrini R; Barnes TA; McDonald J; Hebbes CP; Mela F; Kenigs VA; Marzola G; Rizzi D; Gavioli E; Zucchini S; Regoli D; Morari M; Salvadori S; Rowbotham DJ; Lambert DG; Kapusta DR; Calo' G
J Pharmacol Exp Ther; 2005 Mar; 312(3):1114-23. PubMed ID: 15509719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]